|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 47/50 | (2017.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3126388 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15712472.8 |
| Date of filing the European patent application | 2015-03-10 | |
| (97) | Date of publication of the European application | 2017-02-08 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-08 |
| (46) | Date of publication of the claims translation | 2019-08-26 |
| (86) | Number | PCT/US2015/019722 |
| Date | 2015-03-10 |
| (87) | Number | WO 2015/138460 |
| Date | 2015-09-17 |
| (30) | Number | Date | Country code |
| 201461950963 P | 2014-03-11 | US |
| (72) |
KIRSHNER, Jessica R., US
MACDONALD, Douglas, US
THURSTON, Gavin, US
MARTIN, Joel H., US
DELFINO, Frank, US
NITTOLI, Thomas, US
KELLY, Marcus, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnai prieš EGFRvIII ir jų panaudojimo būdai |
| ANTI-EGFRvIII ANTIBODIES AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2026-02-19 | 12 | 289.00 EUR |
| 2027-03-10 |